scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1104901340 |
P356 | DOI | 10.1007/S00508-018-1351-Y |
P932 | PMC publication ID | 6061656 |
P698 | PubMed publication ID | 29916054 |
P50 | author | Thomas Reiberger | Q42987335 |
Michael Trauner | Q62560551 | ||
Cihan Ay | Q66126625 | ||
P2093 | author name string | Johannes Thaler | |
Ahmed Ba-Ssalamah | |||
Theresa Bucsics | |||
Arnulf Ferlitsch | |||
Bernhard Scheiner | |||
Philipp Schwabl | |||
Mattias Mandorfer | |||
Andrea Brichta | |||
Katharina Lampichler | |||
Paul René Stammet | |||
Sebastian Pokorny | |||
P2860 | cites work | Direct Oral Anticoagulants in Cirrhosis. | Q30277086 |
Direct Oral Anticoagulants in Cirrhosis Patients Pose Similar Risks of Bleeding When Compared to Traditional Anticoagulation. | Q30277819 | ||
The burden of liver disease in Europe: a review of available epidemiological data | Q30590517 | ||
Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23,796 consecutive autopsies | Q33867344 | ||
Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies | Q34468844 | ||
Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension | Q34621625 | ||
Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation | Q35597379 | ||
Prognostic indicators of survival in patients with compensated and decompensated cirrhosis | Q37019451 | ||
The coagulopathy of chronic liver disease | Q37900633 | ||
Natural course of extrahepatic nonmalignant partial portal vein thrombosis in patients with cirrhosis. | Q38034516 | ||
Management of nonneoplastic portal vein thrombosis in the setting of liver transplantation: a systematic review | Q38057976 | ||
Portal vein thrombosis in patients with end stage liver disease awaiting liver transplantation: outcome of anticoagulation. | Q38073664 | ||
Treatment of Patients with Cirrhosis | Q38936166 | ||
Survival and prognostic indicators in compensated and decompensated cirrhosis | Q41784287 | ||
Efficacy and safety of anticoagulation therapy with different doses of enoxaparin for portal vein thrombosis in cirrhotic patients with hepatitis B. | Q42149808 | ||
Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis | Q43281073 | ||
Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis: results of a longitudinal study. | Q44367721 | ||
Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis. | Q44439466 | ||
Risk of venous thromboembolism in patients with liver disease: a nationwide population-based case-control study | Q44540902 | ||
Coagulation parameters in patients with cirrhosis and portal vein thrombosis treated sequentially with low molecular weight heparin and vitamin K antagonists | Q45856891 | ||
Detection of the imbalance of procoagulant versus anticoagulant factors in cirrhosis by a simple laboratory method | Q45861584 | ||
Enoxaparin reduces hepatic vascular resistance and portal pressure in cirrhotic rats | Q45881741 | ||
Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis. | Q51397672 | ||
EASL Clinical Practice Guidelines: Vascular diseases of the liver | Q58034369 | ||
Expanding consensus in portal hypertension | Q58034372 | ||
Enoxaparin Prevents Portal Vein Thrombosis and Liver Decompensation in Patients With Advanced Cirrhosis | Q58034394 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 13-14 | |
P921 | main subject | thrombosis | Q261327 |
portal vein thrombosis | Q1704044 | ||
anticoagulation | Q63279445 | ||
P304 | page(s) | 446-455 | |
P577 | publication date | 2018-06-18 | |
P1433 | published in | Vienna Clinical Weekly | Q15759796 |
P1476 | title | Anticoagulation in non-malignant portal vein thrombosis is safe and improves hepatic function. | |
P478 | volume | 130 |
Search more.